sirolimus-eluting balloon

Sirolimus-Eluting Balloons in Coronary In-Stent Restenosis: Comparative Efficacy Against Repeat DES and Balloon Angioplasty

By MedXY 07/07/2026

The SELUTION4ISR trial demonstrates that sirolimus-eluting balloons are a safe and effective noninferior alternative to standard care, including repeat drug-eluting stents, for treating coronary in-stent restenosis at 1 year.

Cardiology news

Can a Sirolimus-Eluting Balloon Reduce Stent Use in De Novo Coronary Disease? New Randomized Evidence from SELUTION DeNovo

By MedXY 06/15/2026

A large randomized trial found sirolimus-eluting balloon with provisional stenting noninferior to routine DES at 1 year by intention-to-treat analysis, though repeat revascularization was slightly higher and per-protocol noninferiority was not confirmed.

Cardiology news

Can a Sirolimus-Eluting Balloon Strategy Rival Routine Stenting in De Novo Coronary Lesions? New Randomized Trial Says Maybe

By MedXY 06/15/2026

An SEB plus provisional stenting strategy was noninferior to routine DES at 1 year for target vessel failure, but repeat revascularization was modestly higher and per-protocol noninferiority was not confirmed.